WPRIM Management System> DCMS> Korean Journal of Blood Transfusion> 2015> 26

Volume: 26

1. Application of a Grey Zone for HCV and HIV Immunoassays for Blood Donor Screening: Is It still Necessary?. Page:204—212
2. Residual Risk of Transfusion-Transmitted Infection with Hepatitis C Virus since the Introduction of Nucleic Acid Testing in Korea. Page:193—203
3. Gene Frequency of Human Neutrophil Alloantigen-3 in the Korean Population. Page:185—192
4. Human Neutrophil Alloantigen-3a Alloimmunization among Pregnant Korean Women. Page:174—184
5. Survey on the Usage of Leukocyte Reduced and Irradiated Blood Components in Korea (2007~2013). Page:159—173
6. Reporting System of Transfusion Adverse Reaction Using Electronic Medical Records Data. Page:152—158
7. Analysis Survey on Changes in Hospital Blood Donation Center and Satisfaction Level with the Korean Red Cross. Page:142—151
8. Evaluation of Clinical Parameters and Symptoms in Healthy Donors for Granulocyte Collection. Page:132—141
9. Correlation between the Severity of Bone Pain and the Amount of CD34+ Cells after Peripheral Blood Stem Cell Mobilization. Page:123—131
10. Biological Meaning of the Histo-Blood Group Antigens Composed of Sugar Chains. Page:103—122
11. Retraction: Experience of Therapeutic Plasma Exchange in Patients with Severe Fever with Thrombocytopenia Syndrome. Page:81—81
12. Therapeutic Plasma Exchange for a Patient with Severe Cold Agglutinin Disease. Page:75—80
13. A Clinical Experience of Massive Transfusion in a Patient with Cardiac Arrest Resulting from Abdominal Aortic Aneurysm Rupture. Page:70—74
14. Report on External Proficiency Testing for the ABO and D Blood Group Typing Tests in Blood Centers (2014). Page:60—69
15. Unexpected Antibody Screening Tests Including Di(a) in Patients with a History of Multiple Packed Red Cell Transfusion. Page:54—59
16. Performance Evaluation of Unexpected Antibody Screening Test Including Di(a) Cell Using 3% Surgiscreen Sub-Code D in Korean Multi-Transfused Patients. Page:47—53
17. An Update of Maximum Surgical Blood Order Schedule in Elective Surgery. Page:38—46
18. A Feasibility Study for Cryopreserving Peripheral Blood Stem Cell Collects at High Cell Concentration. Page:26—37
19. Comparison of Serum-Free Media in RBC Differentiation from Human Hematopoietic Stem Cells. Page:18—25
20. A Choice and Precautions of Replacement Fluids for Therapeutic Plasma Exchange. Page:9—17
21. Transfusion Strategy and Laboratory Update on the DEL Variant. Page:1—8
22. Correction: Performance Evaluation of Unexpected Antibody Screening Test Including Dia Cell Using 3% Surgiscreen Sub-Code D in Korean Multi-Transfused Patients. Page:326—326
23. A System for Cryopreservation of Rare Red Blood Cell Units; Right Time to Start. Page:323—325
24. A Case of Washed Platelet Transfusion in a Patient with History of Recurrent Transfusion Reaction. Page:316—322
25. A Case Report of Transfusion-Related Acute Lung Injury Induced in the Patient with HLA Antibody after Fresh Frozen Plasma Transfusion. Page:309—315
26. Consideration of the Improvement of the Confirmatory Assay for the Anti-HTLV Positive Blood Donation. Page:300—308
27. Korean Red Cross HLA-Matched Platelet Donor Registry. Page:291—299
28. Assessment of Serum Ferritin Levels in Plateletpheresis Donors. Page:282—290
29. Evaluation of Two Noninvasive Hemoglobin Testing Devices. Page:273—281
30. An Experience of Patient Involvement in the Pre-Transfusion Checking Process: A Single Center Study. Page:266—272
31. Evaluation of the Automated Immunohematology Analyzer ORTHO VISION for ABO Antibody Titration. Page:257—265
32. Analysis of Unexpected Antibodies Detected in Children: A Single Center Study for 7 Years. Page:249—256
33. Emerging Infectious Disease and Safety of Blood Components. Page:235—248